ノヴォ・ノルディスクの商戦略の長は辞職し,企業のリーダーシップを揺るがす. Novo Nordisk's head of commercial strategy resigns, shaking up the company's leadership.

医薬品業界をリードする ノボ・ノルドスクは 経営陣の変更を発表しました Novo Nordisk, a leading pharmaceutical company, has announced a change in its executive management team. 企業戦略の長は,その職務から脱退し,その結果,企業の指導体制が揺るがした. The head of commercial strategy has stepped down from their position, leading to a shakeup in the company's leadership structure. 変更の理由や代替品の詳細は明らかにされていません. Further details about the reasons for the change and potential replacements have not been disclosed.